Cochrane · systematic review · CD003711

Herbal medicines for viral myocarditis

Liu Zhao Lan, Liu Zhi Jun, Liu Jian Ping, et al. · Cochrane Database of Systematic Reviews · 2013 · Cochrane Library

Heart3 versionsAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
12
current version
GRADE rated
12
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 5 · 41.7%Low 3 · 25%Moderate 4 · 33.3%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Show all 3 versions

Herbal medicines versus supportive therapy for viral myocarditis

Population: patients with viral myocarditis
2 questions
OutcomeEffectEvidenceStatus / GRADE
Number of patients died of cardiac failure: Astragaloside injection versus supportive therapy
Herbal medicines vs supportive therapy
RR 1.22 [0.34, 4.38]1 study · 164 participantsVery low
Downgraded: risk of bias, imprecision
Number of patients with premature beat: Xinshu capsule versus supportive therapy
Herbal medicines vs supportive therapy
RR 0.84 [0.56, 0.99]1 study · 120 participantsVery low
Downgraded: risk of bias, imprecision

Herbal medicines plus supportive therapy for viral myocarditis

Population: patients with viral myocarditis
9 questions
OutcomeEffectEvidenceStatus / GRADE
Number of patients with premature beat: Qi Lu decoction plus supportive therapy versus supportive therapy alone
RR 0.71 [0.5, 1]1 study · 111 participantsLow
Downgraded: risk of bias
Number of patients with premature beat: Shortscape Fleabane injection plus supportive therapy versus supportive therapy alone
RR 0.9 [0.67, 1.2]1 study · 83 participantsLow
Downgraded: risk of bias
Number of patients with premature beat: Astragaloside injection plus supportive therapy versus supportive therapy alone
RR 1.09 [0.69, 1.71]1 study · 93 participantsLow
Downgraded: risk of bias
Number of patients with premature beat: Compound Qiangqi pill plus supportive therapy versus supportive therapy alone
RR 0.8 [0.36, 1.77]1 study · 14 participantsModerate
Downgraded: imprecision
Number of patients with premature beat: Shengmai decoction plus supportive therapy versus supportive therapy alone
RR 1 [0.52, 1.94]1 study · 14 participantsModerate
Downgraded: imprecision
Number of patients with premature beat: Danhong injection plus supportive therapy versus supportive therapy alone
RR 0.48 [0.24, 0.96]1 study · 61 participantsModerate
Downgraded: risk of bias
Number of patients with arrhythmia: Astragaloside injection plus supportive therapy versus supportive therapy alone
RR 0.47 [0.14, 1.18]1 study · 43 participantsVery low
Downgraded: risk of bias, imprecision
Number of patients with arrhythmia: Garlicin injection plus supportive therapy versus supportive therapy alone
RR 0.22 [0.05, 0.86]1 study · 44 participantsVery low
Downgraded: risk of bias, imprecision
Number of patients with arrhythmia: Danhong injection plus supportive therapy versus supportive therapy alone
RR 0.71 [0.45, 1.04]1 study · 224 participantsModerate
Downgraded: risk of bias

Herbal medicines plus supportive therapy for viral myocarditis

Population: patients with viral myocarditis
1 question
OutcomeEffectEvidenceStatus / GRADE
Number of patients with premature beat: Astragaloside injection plus supportive therapy versus Acyclovir plus supportive therapy
RR 0.31 [0.09, 0.83]1 study · 73 participantsVery low
Downgraded: risk of bias, imprecision